Facebook Linkedin RSS Twitter Youtube
Home 2024

Illumina Ventures

Illumina Ventures Labs Adds Sequencing to Integrated Biosciences’ “Ultimate” Drug Screening
Artificial Intelligence

Illumina Ventures Labs Adds Sequencing to Integrated Biosciences’ “Ultimate” Drug Screening

Illumina, Icahn Spar over Board Indemnification for Grail Purchase
News

Illumina, Icahn Spar over Board Indemnification for Grail Purchase

AGBT Meets High Standards, Gets Low, Low, Low…
Industry News

AGBT Meets High Standards, Gets Low, Low, Low…

StockWatch: Analysts Mixed on Illumina after Q4 Results, Delivery of First NovaSeq X Plus System
Cancer

StockWatch: Analysts Mixed on Illumina after Q4 Results, Delivery of First NovaSeq X Plus System

Spatial and NGS Dominate Proceedings at AGBT 2022
Insights

Spatial and NGS Dominate Proceedings at AGBT 2022

EY Eyes Comeback for Biopharma M&A
GEN Edge

EY Eyes Comeback for Biopharma M&A

Baylor Study Suggests Commercial Methylation Arrays Not Ideal for Population Epigenetics
News

Baylor Study Suggests Commercial Methylation Arrays Not Ideal for Population Epigenetics

The NGS Race Is On: Souped-Up Sequencers Vie for Frontrunner Status
Insights

The NGS Race Is On: Souped-Up Sequencers Vie for Frontrunner Status

At JPM, Illumina Announces African-American Sequencing Collaboration
Cancer

At JPM, Illumina Announces African-American Sequencing Collaboration

StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure
Cancer

StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure

123...15Page 1 of 15
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.